Researchers have discovered how low doses of ketamine target specific sites on NMDA receptors to rapidly alleviate depression. This binding explains ketamine’s fast-acting and long-lasting antidepressant effects, different from its anesthetic uses at higher doses. The study, involving detailed molecular simulations, paves the way for developing new, potentially non-addictive antidepressants. Groundbreaking Ketamine Research Neuroscientists at […]
